Skip to main content
Livermore
Livermore
ZHEN

Arkadios Wealth Advisors

SEC CIK
0001800798
Latest filing
Aug 10, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by Arkadios Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q2 2026)
1,849
Value
$663.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of WST by Arkadios Wealth Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,849$663.8K<0.1%−65−3.4%ReducedHolders
Q1 20261,914$479.9K<0.1%−215−10.1%ReducedHolders
Q4 20252,129$585.8K<0.1%−105−4.7%ReducedHolders
Q3 20252,234$586.1K<0.1%+969+76.6%AddedHolders
Q2 20251,265$276.9K<0.1%+10+0.8%AddedHolders
Q1 20251,255$281.1K<0.1%−9−0.7%ReducedHolders
Q4 20241,264$414.2K<0.1%+66+5.5%AddedHolders
Q3 20241,198$359.7K<0.1%+211+21.4%AddedHolders
Q2 2024987$325.2K<0.1%+8+0.8%AddedHolders
Q1 2024979$387.6K<0.1%−8−0.8%ReducedHolders
Q4 2023987$347.7K<0.1%−258−20.7%ReducedHolders
Q3 20231,245$467.0K<0.1%−48−3.7%ReducedHolders
Q2 20231,293$494.4K0.1%−112−8.0%ReducedHolders
Q1 20231,405$486.7K0.1%+228+19.4%AddedHolders
Q4 20221,177$277.1K<0.1%−212−15.3%ReducedHolders
Q3 20221,389$342.0K0.1%+104+8.1%AddedHolders
Q2 20221,285$389.0K0.1%+335+35.3%AddedHolders
Q1 2022950$390.0K0.1%−575−37.7%ReducedHolders
Q4 20211,525$715.0K0.1%−363−19.2%ReducedHolders
Q3 20211,888$801.0K0.1%−855−31.2%ReducedHolders
Q2 20212,743$985.0K0.1%+2,643+2,643.0%AddedHolders
Q1 2021100$28.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.